Home » Stocks » LHDX

Lucira Health, Inc. (LHDX)

Stock Price: $12.00 USD -1.88 (-13.54%)
Updated Mar 5, 2021 4:00 PM EST - Market closed
After-hours: $12.16 +0.16 (1.33%) Mar 5, 6:56 PM
Market Cap 459.75M
Revenue (ttm) n/a
Net Income (ttm) -22.20M
Shares Out 37.05M
EPS (ttm) -0.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $12.00
Previous Close $13.88
Change ($) -1.88
Change (%) -13.54%
Day's Open 13.54
Day's Range 11.61 - 14.40
Day's Volume 794,074
52-Week Range 11.61 - 37.99

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 3 weeks ago

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online...

Business Wire - 3 weeks ago

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and inno...

Business Wire - 1 month ago

EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and inno...

NASDAQ - 1 month ago

Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, filed on Friday with the SEC to raise up to $115 million in an initial public offering.

SEC - 1 month ago

Lucira Health, Inc. has filed to go public with an IPO on the NASDAQ.

The New York Times - 2 months ago

Amid surging coronavirus cases, the top U.S. testing official on Thursday announced another scale-up in the country’s diagnostic efforts, touting the importance of tests that can run from star...

About LHDX

Lucira Health, a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops testing platform that provides molecular testing services. The company offers LUCIRA COVID- 19 All- In- One Test Kit, that provides COVID- 19 result; and develops influenza A and B viruses test kits. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.

Industry
Diagnostics & Research
IPO Date
Feb 5, 2021
CEO
Erik T. Engelson
Employees
57
Stock Exchange
NASDAQ
Ticker Symbol
LHDX
Full Company Profile

Financial Performance

Financial Statements